Vilya

Computational approach to drug discovery.

Edited:

📋 Overview of Vilya

Founding Year

2022

Estimated Funding

$0000

Size

$0000

Locations

Seattle

Primary Industry

Precision Medicine

📙 About Vilya

Vilya is a computational biotechnology company that targets disease biology. It designs molecular structures not found in nature, opening doors to therapies for previously untreatable conditions. Their platform eliminates the need for traditional high-throughput screening, accelerating drug discovery and enabling the creation of more effective, drug-like molecules to transform healthcare and cure diseases.

💰 Recent Investors of Vilya

Altitude Life Science Ventures, ARCH Venture Partners, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.